Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating KH001 for dentin hypersensitivity, focusing on its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• KH001

Snippet

Sponsor: HysensBio Co., Ltd | Conditions: Dentin Hypersensitivity | Phase 2 | Status: COMPLETED